Clinical Trials Directory

Trials / Completed

CompletedNCT00858624

Neurophysiology and Pharmacology of Cough Reflex Hypersensitivity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Jacky Smith · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

A cough lasting more than 2 months is known as a chronic cough, affecting 12-23% of the adult non-smoking population. Chronic cough has many associated complications including incontinence, muscular chest pains, blackouts and depression. Current treatment is often ineffective in these patients. To develop new medications the investigators need to understand more about the mechanisms that can lead to excessive coughing. This study plans to compare a group of 12 healthy volunteers and 12 patients with a chronic cough. The investigators hypothesise that that chronic cough patients have a more sensitive cough reflex as a result central nervous system hyper-excitability (central sensitisation). The investigators will measure cough reflex sensitivity before and after administration of ketamine, a medication that blocks an important receptor in the central nervous system.

Conditions

Interventions

TypeNameDescription
DRUGketamineAdministration of low dose intravenous ketamine. Dose: 0.075mg/kg over 10 minutes followed by 0.005mg/kg/min over 20 minutes. Given as single infusion.

Timeline

Start date
2008-02-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2009-03-10
Last updated
2013-06-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00858624. Inclusion in this directory is not an endorsement.